{"id":"https://openalex.org/W2747396160","doi":"https://doi.org/10.1371/journal.pone.0183390","title":"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing","display_name":"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing","alternate_titles":[],"publication_year":2017,"publication_date":"2017-08-24","ids":{"openalex":"https://openalex.org/W2747396160","doi":"https://doi.org/10.1371/journal.pone.0183390","mag":"2747396160","pmid":"https://pubmed.ncbi.nlm.nih.gov/28837681","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5570333"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0183390","doi":"https://doi.org/10.1371/journal.pone.0183390","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0183390","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183390&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2747396160"],"child_works_count":16,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183390&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111958477","display_name":"Sandra L. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/project-administration","display_name":"Project administration"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Sandra L. Ross","raw_affiliation_strings":["Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112198453","display_name":"Marika Sherman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/visualization","display_name":"Visualization"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Marika Sherman","raw_affiliation_strings":["Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112425602","display_name":"Patricia L. McElroy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Patricia L. McElroy","raw_affiliation_strings":["Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113524890","display_name":"Julie A. Lofgren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Julie A. Lofgren","raw_affiliation_strings":["Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032290146","display_name":"Gordon E. Moody","orcid":"https://orcid.org/0009-0001-6949-6855","observed_orcids":["https://orcid.org/0009-0001-6949-6855"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Gordon Moody","raw_affiliation_strings":["Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058901224","display_name":"Patrick A. Baeuerle","orcid":"https://orcid.org/0009-0006-7117-2784","observed_orcids":["https://orcid.org/0009-0006-7117-2784"]},"institutions":[{"id":"https://openalex.org/I4210121112","display_name":"Amgen (Germany)","ror":"https://ror.org/02ezy5072","country_code":"DE","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210121112"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Patrick A. Baeuerle","raw_affiliation_strings":["Department of Amgen Research Munich, Amgen Inc., Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Amgen Research Munich, Amgen Inc., Munich, Germany","institution_ids":["https://openalex.org/I4210121112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001120662","display_name":"Angela Coxon","orcid":"https://orcid.org/0009-0000-3341-0645","observed_orcids":["https://orcid.org/0009-0000-3341-0645"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Angela Coxon","raw_affiliation_strings":["Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090335192","display_name":"Tara Arvedson","orcid":"https://orcid.org/0000-0001-9375-3017","observed_orcids":["https://orcid.org/0000-0001-9375-3017"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Tara Arvedson","raw_affiliation_strings":["Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":"https://orcid.org/0000-0001-9375-3017","affiliations":[{"raw_affiliation_string":"Department of Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5090335192"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":4.0465,"has_fulltext":true,"cited_by_count":137,"citation_normalized_percentile":{"value":0.95114735,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"12","issue":"8","first_page":"e0183390","last_page":"e0183390"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.08330000191926956,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.05620000138878822,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9819999933242798},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.8799999952316284},{"id":"https://openalex.org/keywords/bystander-killing","display_name":"bystander killing","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.6769999861717224},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.6320000290870667},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.7879999876022339},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7089999914169312},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.8209999799728394},{"id":"https://openalex.org/keywords/fas","display_name":"Fas","score":0.9110000133514404},{"id":"https://openalex.org/keywords/cytokines","display_name":"cytokines","score":0.6949999928474426},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.7908761501312256},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.5597354173660278},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5469626784324646},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5210782289505005},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5075861215591431},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46118173003196716},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.43218931555747986},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41675862669944763},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41344454884529114},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.29363903403282166},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.24643555283546448},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018920","descriptor_name":"Coculture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024201","descriptor_name":"Bystander Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1371/journal.pone.0183390","doi":"https://doi.org/10.1371/journal.pone.0183390","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0183390","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183390&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4485711","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5570333","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5570333","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5570333/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:28837681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28837681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:da6de4d7994f403384257b718f9d5ae2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/da6de4d7994f403384257b718f9d5ae2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 12, Iss 8, p e0183390 (2017)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/5343208","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Bispecific_T_cell_engager_BiTE_sup_sup_antibody_constructs_can_mediate_bystander_tumor_cell_killing/5343208","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0183390","doi":"https://doi.org/10.1371/journal.pone.0183390","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0183390","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183390&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2747396160.pdf","grobid_xml":"https://content.openalex.org/works/W2747396160.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W1499176694","https://openalex.org/W1516902820","https://openalex.org/W1561756904","https://openalex.org/W1565781452","https://openalex.org/W1578438134","https://openalex.org/W1594920269","https://openalex.org/W1624950583","https://openalex.org/W1692656962","https://openalex.org/W1829982221","https://openalex.org/W1946170591","https://openalex.org/W1963673812","https://openalex.org/W1969730589","https://openalex.org/W1971873029","https://openalex.org/W1980005782","https://openalex.org/W1987913042","https://openalex.org/W1990633837","https://openalex.org/W1993236072","https://openalex.org/W1993325062","https://openalex.org/W1996815863","https://openalex.org/W2008059245","https://openalex.org/W2015956932","https://openalex.org/W2020634797","https://openalex.org/W2025423439","https://openalex.org/W2037681980","https://openalex.org/W2037873230","https://openalex.org/W2044687503","https://openalex.org/W2048773810","https://openalex.org/W2051893458","https://openalex.org/W2057561528","https://openalex.org/W2059739979","https://openalex.org/W2066454038","https://openalex.org/W2068324509","https://openalex.org/W2072590801","https://openalex.org/W2083494119","https://openalex.org/W2088374507","https://openalex.org/W2089122153","https://openalex.org/W2098113133","https://openalex.org/W2104945248","https://openalex.org/W2111742915","https://openalex.org/W2113441188","https://openalex.org/W2113537295","https://openalex.org/W2117692326","https://openalex.org/W2127132803","https://openalex.org/W2128091130","https://openalex.org/W2132415951","https://openalex.org/W2145444883","https://openalex.org/W2147575050","https://openalex.org/W2150995617","https://openalex.org/W2168528728","https://openalex.org/W2213537831","https://openalex.org/W2278340539","https://openalex.org/W2279127916","https://openalex.org/W2402046084","https://openalex.org/W2561836860","https://openalex.org/W3099424780"],"related_works":["https://openalex.org/W2193623085","https://openalex.org/W4313383327","https://openalex.org/W2559821310","https://openalex.org/W3015027884","https://openalex.org/W2324279110","https://openalex.org/W2774900586","https://openalex.org/W2011249140","https://openalex.org/W4386399140","https://openalex.org/W4223505503","https://openalex.org/W7201889099"],"abstract_inverted_index":{"For":[0],"targets":[1],"that":[2,152],"are":[3],"homogenously":[4],"expressed,":[5],"such":[6],"as":[7,104],"CD19":[8,22],"on":[9,164],"cells":[10,37,125,134,141],"of":[11,56,71,110,160],"the":[12,57,93],"B":[13],"lymphocyte":[14],"lineage,":[15],"immunotherapies":[16,75],"can":[17],"be":[18,82],"highly":[19],"effective.":[20],"Targeting":[21],"with":[23,32,53,76,120],"blinatumomab,":[24],"a":[25,63,77,85,105],"CD19/CD3":[26],"bispecific":[27],"antibody":[28,130],"construct":[29],"(BiTE\u00ae),":[30],"or":[31],"chimeric":[33],"antigen":[34,59],"receptor":[35,102],"T":[36,124,140,170],"(CAR-T)":[38],"has":[39],"shown":[40],"great":[41],"promise":[42],"for":[43,65],"treating":[44],"certain":[45],"CD19-positive":[46],"hematological":[47],"malignancies.":[48],"In":[49],"contrast,":[50],"solid":[51,94],"tumors":[52],"heterogeneous":[54],"expression":[55],"tumor-associated":[58],"(TAA)":[60],"may":[61],"present":[62],"challenge":[64],"targeted":[66],"therapies.":[67],"To":[68],"prevent":[69],"escape":[70],"TAA-negative":[72],"cancer":[73],"cells,":[74,122,167],"local":[78],"bystander":[79,90,166,172],"effect":[80],"would":[81],"beneficial.":[83],"As":[84],"model":[86],"to":[87,145,169],"investigate":[88],"BiTE\u00ae-mediated":[89],"killing":[91],"in":[92,113,116],"tumor":[95],"setting,":[96],"we":[97],"used":[98],"epidermal":[99],"growth":[100],"factor":[101],"(EGFR)":[103],"target.":[106],"We":[107],"measured":[108],"lysis":[109],"EGFR-negative":[111,133,165],"populations":[112],"vitro":[114],"and":[115,126,162],"vivo":[117],"when":[118,143],"co-cultured":[119],"EGFR-positive":[121,146],"human":[123],"an":[127],"EGFR/CD3":[128],"BiTE\u00ae":[129],"construct.":[131],"Bystander":[132],"were":[135],"efficiently":[136],"lysed":[137],"by":[138,155],"BiTE\u00ae-activated":[139,156],"only":[142],"proximal":[144],"cells.":[147],"Our":[148],"mechanistic":[149],"analysis":[150],"suggests":[151],"cytokines":[153],"released":[154],"T-cells":[157],"induced":[158],"upregulation":[159],"ICAM-1":[161],"FAS":[163],"contributing":[168],"cell-induced":[171],"cell":[173],"lysis.":[174]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2747396160","counts_by_year":[{"year":2026,"cited_by_count":21},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-08-31T00:00:00"}
